Montréal
OncologyEducation’s Best of ASCO® Montreal 2023 Conference is a program licensed by the American Society of Clinical Oncology® and will be an all-day hybrid event on July 12th, 2023. Chaired by Dr. Jamil Asselah and Dr. Kim Ma, the focus of this event will be to provide medical oncologists and other healthcare practitioners with a summary of the most significant treatment advances presented at The 2023 ASCO® Annual Meeting, with presentations focused on several key disease sites. The Best of ASCO® Montreal 2023 faculty will draw from some of Canada’s most influential oncologists.
Learning Objectives
- To summarize the most significant treatment advances presented at The 2023 ASCO® Annual Meeting
- To review the current standard of care for key malignancies
- To discuss the current controversies in the management of specific cancers
Wednesday, July 12, 2023
2:00 p.m – 9:05 p.m. ET
In Person & Free Virtual Registration Options Below:
Registration for Healthcare professionals can be completed above. Industry representatives (both sponsor and non-sponsor) must contact Kelly Allan at kelly@oncologyeducation.ca for registration and sponsorship opportunities.
Join Us Live In Person at the
InterContinental Montreal
Scientific Agenda
Times listed are EDT
2:00 p.m. – 2:45 p.m.
Registration and Refreshments
2:45 p.m. – 2:55 p.m.
Welcome Address by Chairs – Dr. Jamil Asselah & Dr. Kim Ma
2:55 p.m. – 3:40 p.m.
Gilead Mid-Afternoon Symposium: Where Do We Stand with Triple-Negative Breast Cancer? A Case-Based Discussion.
3:40 p.m. – 4:05 p.m.
Melanoma – Dr. Khashayar Esfahani
4:05 p.m. – 4:30 p.m.
Neoadjuvant Breast Cancer – Dr. Nicholas Meti
4:30 p.m. – 4:50 p.m.
Networking Break & Sponsor Exhibits
4:50 p.m. – 5:05 p.m.
Metastatic Breast Cancer – Dr. Jamil Asselah
5:05 p.m. – 5:20 p.m.
GU Updates
5:20 p.m. – 5:35 p.m.
Lung Cancer – Dr. Elie Kassouf
5:35 p.m. – 6:00 p.m.
Colorectal GI Cancer
6:00 p.m. – 6:25 p.m.
Non-Colorectal GI Cancer – Dr. Petr Kavan
6:25 p.m. – 6:55 p.m.
Dinner Buffet & Networking Break
6:55 p.m. – 7:40 p.m.
Merck Dinner Symposium: Precision Oncology – Keeping your Pathologist Close – Dr. Chelsea Maedler-Kron
7:40 p.m. – 8:05 p.m.
Practice Changing Data – Dr. Kim Ma
8:05 p.m. – 8:30 p.m.
Non-Myeloma Hematology
8:30 p.m. – 8:55 p.m.
Myeloma – Dr. Richard LeBlanc
8:55 p.m. – 9:05 p.m.
Closing Remarks by Chairs – Dr. Jamil Asselah & Dr. Kim Ma
About the Faculty
Dr. Jamil Asselah
Conference Chair
Trained in Algiers and Paris as a medical oncologist, Dr. Asselah completed a 2-year fellowship on phase 1 clinical trials at the Investigation Unit of the Curie Institute Cancer Center in Paris, France.
In 2008, he joined the Université de Sherbrooke as an Assistant Professor, developing new research protocols in breast cancer and standardizing treatment practices at the Centre Hospitalier Universitaire de Sherbrooke, where he also launched theoncology residency program.
Dr. Asselah joined McGill in 2011 as an Assistant Professor in the Department of Oncology, and is now Associate Professor. He is on staff as a medical oncologist at the McGill University Health Centre, where he spearheaded a working group standardizing treatment guidelines for breast cancer. He was the first Site Lead for the Rossy Cancer Network. Dr. Asselah has been the principal investigator in numerous clinical research protocols and has been part of several research groups at the provincial and national levels. His research interests include breast cancers, gastrointestinal cancers, and cancers of the head and neck. Dr. Asselah is also a leader of the “Opal” team and has been involved in the development and implementation of “Opal,” an innovative patient portal that provides patients with immediate access to their personal health information.
More recently with the spread of the COVID-19 pandemic in Québec, Dr. Asselah has assumed a leadership role through his work with the Ministère de la Santé et des Services sociaux (MSSS), helping to coordinate efforts to mitigate risks to cancer patients despite the constraints imposed by the current situation.
Dr. Kim Ma
Conference Chair
Dr. Kim Ma studied hematology, oncology, and internal medicine at McGill University in Montréal, Canada. Dr. Ma is a recipient of the J.W. McConnell Award, the Student Research Award F.R.S.Q., the Millennium Award of Excellence, the McGill Entrance Award, and the Science Award at McGill University. She has a special interest in thrombosis, and thus focuses much of her research in this area. Most recently, Dr. Ma helped investigate the ELOPE Study, which looked at serial imaging after pulmonary embolism and correlation with functional limitations.
Sponsorship
For sponsorship-related inquiries, please contact Bernadette Gregoris at bernadette@oncologyeducation.com.
PLATINUM
GOLD
SILVER
BRONZE
ASCO® is a registered trademark of the American Society of Clinical Oncology. All rights reserved.